SRA's number for the day: 3,000
This article was originally published in SRA
Executive Summary
Over 3,000 clinical trials are currently under way in China, a large proportion of which are sponsored by global pharmaceutical companies, says an academic team, which is calling for a revision of the model by which trials in emerging markets are conducted1.